Article

Safety, effectiveness, and skin immune response in a controlled human infection model of sand fly transmitted cutaneous leishmaniasis

2024-04-13

Abstract excerpt

The leishmaniases are globally important parasitic diseases for which no human vaccines are currently available. To facilitate vaccine development, we conducted an open label observational study to establish a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis caused by L. major . Between 24 th January and 12 th August 2022, we exposed 14 (8F, 6M) participants to infected Phlebotomus...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8b7185e2-83f4-5b62-b1cd-717e81d90fb0
DOI: 10.1101/2024.04.12.24305492

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Safety, effectiveness, and skin immune response in a controlled human infection model of sand fly transmitted cutaneous leishmaniasisDOI 10.1101/2024.04.12.24305492Read

Unraveling the Immune Response Dynamics of Leishmaniasis: Insights, Challenges, and Vaccine DevelopmentSemantic proximity Read

Skin parasite landscape determines host infectiousness in visceral leishmaniasisSemantic proximity Read

Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasisSemantic proximity Read

The changing epidemiology of human leishmaniasis in the non-endemic country of Austria between 2000 to 2021, including a congenital caseSemantic proximity Read

Protocol for a prospective observational cohort study of cutaneous leishmaniasis in EthiopiaSemantic proximity Read

Genomic Analysis of Two Phlebotomine Sand Fly Vectors of <i>Leishmania</i> from the New and Old WorldSemantic proximity Read

Diversity of sand flies and Leishmania parasites in an active cutaneous leishmaniasis transmission site in rural Guatemala, 2022Semantic proximity Read

Protective or Detrimental? Understanding the Role of Host Immunity in LeishmaniasisSemantic proximity Read

A Second Generation Leishmanization Vaccine with a Markerless Attenuated <i>Leishmania major</i> Strain using CRISPR gene editingSemantic proximity Read

Vaccine candidates, immuno-dominant antigens, and potent vaccine adjuvants for preventing cutaneous leishmaniasis: a sysSemantic proximity Read

Tegumentary Leishmaniasis: Perspectives and Challenges in This Enigmatic DiseaseSemantic proximity Read

The molecular and histopathological investigations of TLR2 rs5743708 and TLR4 (rs4986790 and rs4986791) polymorphisms effects on cutaneous leishmaniasis lesions.Semantic proximity Read